Trial Profile
A prospective clinical trial to evaluate the V4 Drug delivery device for long term delivery of Ranibizumab for the Treatment of Choroidal Neovascularization
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Oct 2014
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Age-related macular degeneration; Choroidal neovascularisation
- Focus Therapeutic Use
- Sponsors ForSight VISION4
- 10 Oct 2014 New trial record